-Live Mint Mahindra and Mahindra Ltd, the world’s biggest tractor maker by volume, cut its forecast for sales growth of the farm equipment in India as the worst rainfall in three years delays crop sowing. Mahindra estimates industry sales to expand as little as 2% in the year ending 31 March, Pawan Goenka, president of the automotive and farm equipment division at the Mumbai-based company, said in an email response on Thursday. Goenka...
More »SEARCH RESULT
Total Matching Records found : 2634
Jairam Ramesh calls for freeze on fresh mining in worst Naxal-affected regions-Urmi Goswami
-The Economic Times Rural Development Minister Jairam Ramesh has pitched for a moratorium on new mining projects in the worst Naxal-affected regions and particularly in areas recently recaptured from insurgents, saying it was essential to quell the Maoist problem wreaking havoc across much of India's hinterland. Tribal affairs minister Kishore Chandra Deo had earlier made this suggestion. In comments certain to draw the ire of industry, parts of which already view him...
More »Food, the new crisis-CP Chandrasekhar
-Frontline A recession-hit world is only just waking up to the prospect of the coming food crisis resulting in a period of political turmoil with unexpected consequences. For the third time in five years, the world is braced for another food crisis. Bad weather conditions are leading to projections of major production shortfalls in some of the world’s leading food suppliers. Substantially reduced access and sharp price increases are, therefore, expected to...
More »Maharahstra, TN account for 36% of sub-standard drugs -Kounteya Sinha
-The Times of India Almost one in three drugs (36%) found "not of standard quality" from across India last year were from Maharashtra (23%) and Tamil Nadu (13%) alone. Around 9.2% of the rest of the sub-standard quality drugs were from Kerala, Gujarat (8.5%), Karnataka (7.2%), Uttar Pradesh (6.9%), Jammu & Kashmir (6.08%) and Rajasthan (5.8%). Union health minister Ghulam Nabi Azad said on Tuesday that of the 48, 082 drug samples tested...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
